Maybe. it often moves double the bio indexes up or down. so I don't know if it got ahead or not. I think technically it was overbought. Maybe the drop will help the charts some. mongus might be better able to answer that. It does seem like the selling pressure subsided today as we finished green.
From Leerink: For NBIX, the data, as well as the company's
APA event in the evening, offered incremental positives relative to the
American Academy of Neurology (AAN) presentation. Meanwhile, for
TEVA, the APA poster represents the first time that SD-809 TD data
were presented beyond the prior top-line release last summer. While
our TD revenue model continues to assume a 50/50 market share split
which reflects TEVA's significant commercial advantage in neurology, the
APA presentations reaffirm our confidence that despite the compounds'
identical mechanisms-of-action, valbenazine may have an incrementally
better product profile.